A pill a day can prevent HIV, but there’s no guarantee Australians will get access to this life saving drug anytime soon, writes Bridget Haire.
A cognitively enhanced society is neither inevitable nor unobjectionable, write Emma A Jane and Nicole A Vincent.
Her vision is to use nanotechnology to deliver drugs and gene-silencing therapies directly to cancer cells. He is a social scientist with an interest in the social and ethical issues of technological change.
Evaluations of research ethics do not benefit from a tick-box approach, writes Gigi Foster.
The vigil for convicted drug smugglers Andrew Chan and Myuran Sukumaran showed the two men and their families that "lots of people walk this path with you," writes Joanna Mendelssohn.
UNSW ethicist Dr Bridget Haire says doctors working in immigration detention face tough ethical dilemmas and may find themselves unable to fulfill their professional obligations.
Career networking is an immoral attempt to gain an illegitimate advantage over others, Ned Dobos argues.
When it comes to reporting the projected consequences of climate change, are journalists following their conscience or are they letting us, and future generations, down, asks Tim Dean.
Scandals implicating pharmaceutical companies show we need better strategies if “corporate integrity” is to mean anything in the globalised medicine market, write Wendy Lipworth and Ian Kerridge.
An Australian-first survey co-authored by David McKnight shows that despite newspapers moving online, the majority of media professionals are still committed to quality, ethical journalism.